Abstract
Bronchiolitis obliterans (BO) is a potentially life-threatening complication following allogeneic stem cell transplantation (SCT) and usually carries a poor prognosis. Immunosuppressive medications are the main treatment, but are rarely effective, especially when the disease is severe. Thus, both early detection and alternative therapeutic approaches of post SCT BO are needed. We report our experience with Budesonide/Formoterol, an inhaled steroid and long-acting bronchodilatator combination, in a group of patients with mild to moderately severe BO after SCT whose systemic immunosuppressive treatment had not been modified. Thirteen patients were treated. The diagnosis of BO was based on the presence of respiratory symptoms and air-trapping on expiratory lung high-resolution computed tomography in all patients, associated with irreversible airflow obstruction in seven cases. The median follow-up was 12.8 months (range: 5–29 months). All patients improved clinically, and both forced expiratory volume in 1 (FEV1) and mean expiratory flow values increased significantly during follow-up (534±268 ml in absolute values and 36±27% compared to pretreatment values for FEV1; P<0.02). These encouraging results provide new insights in the therapeutic approach of BO after SCT and require confirmation in a larger group of patients with a longer follow-up.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Afessa B, Peters SG . Chronic lung disease after hematopoietic stem cell transplantation. Clin Chest Med 2005; 26: 571–586.
Chan CK, Hyland RH, Hutcheon MA, Minden MD, Alexander MA, Kossakowska AE et al. Small-airways disease in recipients of allogeneic bone marrow transplants. An analysis of 11 cases and a review of the literature. Medicine 1987; 66: 327–340.
Clark JG, Crawford SW, Madtes DK, Sullivan KM . Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989; 111: 368–376.
Philit F, Wiesendanger T, Archimbaud E, Mornex JF, Brune J, Cordier JF . Post-transplant obstructive lung disease (‘bronchiolitis obliterans’): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J 1995; 8: 551–558.
Chien JW, Martin PJ, Gooley TA, Flowers ME, Heckbert SR, Nichols WG et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003; 168: 208–214.
Dudek AZ, Mahaseth H, DeFor TE, Weisdorf DJ . Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 2003; 9: 657–666.
Marras TK, Chan CK, Lipton JH, Messner HA, Szalai JP, Laupacis A . Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant 2004; 33: 509–517.
Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948–968.
Franquet T, Muller NL . Disorders of the small airways: high-resolution computed tomographic features. Semin Respir Crit Care Med 2003; 24: 437–444.
Sargent MA, Cairns RA, Murdoch MJ, Nadel HR, Wensley D, Schultz KR . Obstructive lung disease in children after allogeneic bone marrow transplantation: evaluation with high-resolution CT. AJR Am J Roentgenol 1995; 164: 693–696.
Jung JI, Jung WS, Hahn ST, Min CK, Kim CC, Park SH . Bronchiolitis obliterans after allogeneic bone marrow transplantation: HRCT findings. Korean J Radiol 2004; 5: 107–113.
Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997; 100: 44–51.
Battaglia S, Mauad T, van Schadewijk AM, Vignola AM, Rabe KF, Bellia V et al. Differential distribution of inflammatory cells in large and small airways in smokers. J Clin Pathol 2006 (E-pub ahead of print). doi:10.1136/jcp.2006.037002.
Remington TL, Digiovine B . Long-acting beta-agonists: anti-inflammatory properties and synergy with corticosteroids in asthma. Curr Opin Pulm Med 2005; 11: 74–78.
Miller-Larsson A, Selroos O . Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta2-agonists. Curr Pharm Des 2006; 12: 3261–3279.
Yousem SA . The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients. Hum Pathol 1995; 26: 668–675.
Yokoi T, Hirabayashi N, Ito M, Uno Y, Tsuzuki T, Yatabe Y et al. Broncho-bronchiolitis obliterans as a complication of bone marrow transplantation: a clinicopathological study of eight autopsy cases. Virchows Arch 1997; 431: 275–282.
de Jong PA, Dodd JD, Coxson HO, Storness-Bliss C, Pare PD, Mayo JR et al. Bronchiolitis obliterans following lung transplantation: early detection using computed tomographic scanning. Thorax 2006; 61: 799–804.
Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 2002; 100: 406–414.
Leung AN, Fisher K, Valentine V, Girgis RE, Berry GJ, Robbins RC et al. Bronchiolitis obliterans after lung transplantation: detection using expiratory HRCT. Chest 1998; 113: 365–370.
Bankier A, Van Muylem AV, Knoop C, Estenne M, Genevois PA . Bronchiolitis obliterans syndrome in heart–lung transplant recipients: diagnosis with expiratoty CT. Radiology 2001; 218: 533–539.
Lucidarme O, Coche E, Cluzel P, Mourey-Gerosa I, Howarth N, Grenier P . Expiratory CT scans for chronic airway disease: correlation with pulmonary function test results. Am J Roentgenol 1998; 170: 301–307.
Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297–310.
Gerhardt SG, McDyer JF, Girgis RE, Conte JV, Yang SC, Orens JB . Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med 2003; 168: 121–125.
Khalid M, Al Saghir A, Saleemi S, Al Dammas S, Zeitouni M, Al Mobeireek A et al. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study. Eur Respir J 2005; 25: 490–493.
Acknowledgements
We thank M Mao for excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bergeron, A., Belle, A., Chevret, S. et al. Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation. Bone Marrow Transplant 39, 547–553 (2007). https://doi.org/10.1038/sj.bmt.1705637
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705637
Keywords
This article is cited by
-
Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
Respiratory Research (2016)
-
A Call to Arms: a Critical Need for Interventions to Limit Pulmonary Toxicity in the Stem Cell Transplantation Patient Population
Current Hematologic Malignancy Reports (2015)
-
The efficacy of prophylactic azithromycin on bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
International Journal of Hematology (2015)
-
Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis
Bone Marrow Transplantation (2013)
-
What we know and mostly do not know about bronchiolitis obliterans syndrome
Bone Marrow Transplantation (2012)